Mercury Containing Swine flu Vaccine May be Cleared After Five-Day Trial

In London, the Sunday Times is reporting that "When the new vaccine for swine flu arrives in Britain, regulators said this weekend, it could be approved for use in just five days."

No word yet on how long the trials for the H1N1 shots will last in the US.

I have spoken to an official at the Maine health department who is reporting that the vaccine delivered here will be one that comes in multidose vials, therefore will be a mercury containing vaccine.

Last week, HHS secretary Kathleen Sebelius said that HHS was "anticipating a voluntary" H1N1 vaccine program this fall, which leaves room for the possibility that HHS could change their minds and make it mandatory.

I would encourage everyone to keep an eye on this story as it develops, as hastily manufactured, tested and delivered vaccines that are not held up to the same scrutiny that is standard during FDA licensure certainly would have a greater potential for adverse reactions when introduced to the general public.

Swine flu vaccine to be cleared after five-day trial
July 12, 2009
The Sunday Times
byJon Ungoed-Thomas

The path of a popular medicine from the laboratory to the chemist or doctor’s surgery can involve years of clinical trials on a select group of patients.

When the new vaccine for swine flu arrives in Britain, regulators said this weekend, it could be approved for use in just five days.

Regulators at the European Medicines Agency (EMEA) said the fast-tracked procedure has involved clinical trials of a “mock-up” vaccine similar to the one that will be used for the biggest mass vaccination programme in generations. It will be introduced into the general population while regulators continue to carry out simultaneous clinical trials.

The first patients in the queue for the jab - being supplied to the UK by GSK and Baxter Healthcare - may understandably be a little nervous at any possible side effects. A mass vaccination campaign against swine flu in America was halted in the 1970s after some people suffered Guillain-Barré syndrome, a disorder of the nervous system.

However, regulators said fast-tracking would not be at the expense of patient safety. “The vaccines are authorised with a detailed risk management plan,” the EMEA said. “There is quite a body of evidence regarding safety on the trials of the mock-up, and the actual vaccine could be assessed in five days.”

The UK government has ordered enough vaccine to cover the entire population. GPs are being told to prepare for a nationwide vaccination campaign.

Dr Peter Holden, the British Medical Association’s lead negotiator on swine flu, who has been attending Department of Health meetings on the outbreak, said GPs’ surgeries were prepared for one of the biggest vaccination campaigns in almost 50 years.

He said although swine flu was not causing serious illness in patients, health officials were eager to start a mass vaccination campaign, starting first on priority groups. First, the jabs would reduce the chances of a shortage of hospital beds because of people suffering from swine flu. Second, it would reduce the effect on the economy by ensuring workers were protected from the virus.

“The high-risk groups will be done at GPs’ surgeries. People are still making decisions over this, but we want to get cracking before we get a second wave, which is traditionally far more virulent.”

Holden said it was likely the elderly would be given their seasonal flu jab as well as the swine flu vaccination. The new vaccine is likely to require two doses.

Details of the inoculation plans emerged after the death of a patient, reportedly a middle-aged man, at a hospital in the Basildon area of Essex. The victim had no underlying health problems, but officials say there is no evidence the swine flu virus had mutated into a more dangerous strain.

Holden said it would be the biggest campaign in response to an outbreak since mass vaccination against smallpox in 1962. He said surgeries would be aiming to inoculate about 30 people an hour in a “military-style operation”.

The Department of Health said it had still not finalised which groups would be vaccinated first, but children, frontline health workers, people with underlying illnesses and the elderly are likely to take priority.

The European Commission is also identifying population groups which it believes should get priority. It is keen to ensure that countries such as the UK, which had ordered supplies of the vaccine in advance, do not cause inequities in treatment elsewhere in Europe.

It warned health ministers in a note circulated last month that if the vaccines were more readily available in some countries it could cause “vaccine tourism/shopping in other member states”.

About 15 people have died of swine flu in Britain, but most of those infected get only mild symptoms. According to the latest figures from the Health Protection Agency, the UK has had 9,718 confirmed cases of the disease.

Swine Flu Vaccine: Will We Have A Choice?

H1N1 Flu: Mike Wallace of 60 Minutes on the 1976 Swine Flu Vaccine Push

The Federal Government has begun the push of the swine flu vaccine, even before the vaccine has been completed.

It is more than a bit disconcerting to hear that the government is recommending a vaccine, and has decided to administer it in schools, before it has even been completed much less tested. The mantra of CDC on vaccines has always been, "the benefits outweigh the risks". Yet we have no vaccine or test upon which to base a risk/benefit analysis. This for a virus that appears to be less dangerous than the seasonal flu.

In 1976 CDC decided to launch a similar campaign. It was a disaster. Swine flu never came to fruition, and 4,000 people were permanently injured or killed by the shot.

In 1979, 60 Minutes did a story on the damage. It aired only once, but resurfaced last month on the internet.

It is obvious why it only aired once.

It is REMARKABLE how closely this story parallels our own. 30 years later, the CDC seems to have learned nothing about anticipating and dealing properly with vaccine injury. You could have taken these exact same quotes out of this story and put them in an autism story.

So did this exchange happen in 1979 or in 2009?:

Interviewer: "Why does this report from your own agency list neurological complications as a possibility?"

Director of CDC: "I think the consensus of the scientific community was that the evidence relating neurologic disorders to immunizations was such that they did not feel that this association was a real one."

Swine Flu 1976 & Propaganda
Uploaded by Dianequiose-4. - More video blogs and vloggers.

The ads encouraging my parents to get the swine flu shot back then were not PSA's that took seriously their right to informed consent and educated them on the risks and benifits of getting the vaccine, they were PR pieces (including scare tactics, "...but Dotty had a heart condition and she died") put together by Madison Avenue.

Not only has HHS not learned to treat the public respectfully and be straight with them on this vaccine, they have lowered the bar on their PR push... all the way. This advertising push will be brought to you not by reasoned physicians upholding their ethical obligations by offering a comprehensive overview of risks and benifits, it will not even be brought to you by the professional ad men who sell you cars and beer, it will be brought to you by you:


Create a Flu Video & Be Eligible to Win $2500

So now you can not only be entertained by Fred Figglehorn, you can also get your medical advice from him.

HHS gets around these sticky ethical delemma's of being honest with the public and not trading on emotions or fears, by letting the public scare and cajole themselves into getting the shot.

As much as CDC claims that it wants to gain back credibility on vaccine issues, moves like this say different.

I Love Missouri Governor Jay Nixon

Congressional Briefing by Maloney on Vaxxed v. Unvaxxed Bill

Call your Senators and Representatives offices and ask them to attend:

Rep. Maloney and Rep. Smith To Host A Second Autism Congressional Briefing An Update On Federal Autism Research And Treatment Initiatives

PLEASE CONTACT YOUR US SENATORS (HERE) AND MEMBERS OF CONGRESS (HERE) AND URGE THEM TO ATTEND OR SEND A STAFF MEMBER TO THIS IMPORTANT AUTISM-VACCINE BRIEFING ON CAPITOL HILL

Friday, July 17 at 9:30 AM
210 Cannon House Office Building
Independence Avenue, Washington, DC.

FREE AND OPEN TO THE PUBLIC

Rep. Carolyn Maloney (D-NY) and Rep. Christopher Smith (R-NJ) is hosting a special briefing for Members of Congress and their Staff to discuss issues related to autism research and treatment. We hope that you will attend the briefing to learn about the changing dynamics of the autism debate, as you will find many in government and science believe this debate is far from settled.

David Kirby, investigative journalist and author of The New York Times bestseller Evidence of Harm, Mercury in Vaccines and the Autism Epidemic – A Medical Controversy, will inform Members and their staff about developments regarding environmental factors in autism and the “Seven Studies to Watch” – Plus, changing ASD demographics post-thimerosal reduction. Mr. Kirby will also be joined by Mark Blaxill, Editor-at-Large of Age of Autism, Director of the Coalition for SAFE MINDS and co-author of a forthcoming book on the roots of the autism epidemic, who will address the policy and public health implications of the autism crisis.
Among the issues to be discussed are:

• The unanimous endorsement by the National Vaccine Advisory Committee to look at the feasibility of a large vaccinated-unvaccinated study, with autism as an outcome.
• 
  
• The NVAC endorsement of three other vaccine-autism investigations, including children with mitochondrial dysfunction, children with regressive autism, and vaccine injury as a risk factor for ASD.
• 
  
• Recent Vaccine Court decisions finding the MMR and Hep B vaccines caused injuries that led to autism and MS.
• 
  
• The NIH Early Autism Risk Longitudinal Investigations EARLI study and the HHS/EPA National Children’s Study, both of which are looking at vaccination and mercury exposures, with autism as a possible outcome.
• 
  
• The CDC’s Centers for Autism and Developmental Disabilities Research and Epidemiology (CADDRE) Network, whose five-year goal includes studying "specific mercury exposures, including any vaccine use by the mother during pregnancy and the child's vaccine exposures after birth.”
• 
  
• Cleveland Clinic – A recent article in PLoS Online by authors from the Cleveland Clinic, Harvard and Johns Hopkins University reported that, "Large, population-based studies will be needed to identify a possible relationship of vaccination with autistic regression in persons with mitochondrial dysfunction.”
• 
  
• Recent statements by Federal health officials such as Dr. Duane Alexander, Director of the Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), who said it was “legitimate to ask” whether vaccines can trigger autism, and Dr. Anthony Fauci, Director of NIAID, who said in a US News and World report article, “we may want to screen everyone prior to vaccination (for) undetectable diseases like a subclinical mitochondrial disorder."
• 
  
• The U.C. Davis M.I.N.D. Institute study which found, that the seven- to eight-fold increase in the number children born in California with autism since 1990 cannot be explained by either changes in how the condition is diagnosed or counted — and the trend shows no sign of abating. This as young adults begin to flood the social services system
• 
  
• Reports of reduced Autism Spectrum Disorder (ASD) severity among the youngest children, following reduction of thimerosal in childhood vaccines.

Please contact your elected representatives and urge them to attend.
A RUNNING TALLY OF CONGRESSIONAL RSVPS WILL BE KEPT AT WWW.AGEOFAUTISM.COM,
IF YOU RECEIVE ANY REPLY FROM LAWMAKERS IN YOUR STATE, PLEASE FORWARD THAT INFORMATION TO kirbylecture@gmail.com

Babies Born with Genetal Malformations Increasing

Another screaming wake up call that is not being heard by the government health authorities.

Please consider bringing this New York Times column to the attention of your legislator and public health department.

Add that you would like them to get on board with the Environmental Working Group's Kid Safe Chemicals Act.

It’s Time to Learn From Frogs
By NICHOLAS D. KRISTOF
New York Times: June 27, 2009

Some of the first eerie signs of a potential health catastrophe came as bizarre deformities in water animals, often in their sexual organs.


Frogs, salamanders and other amphibians began to sprout extra legs. In heavily polluted Lake Apopka, one of the largest lakes in Florida, male alligators developed stunted genitals.

In the Potomac watershed near Washington, male smallmouth bass have rapidly transformed into “intersex fish” that display female characteristics. This was discovered only in 2003, but the latest survey found that more than 80 percent of the male smallmouth bass in the Potomac are producing eggs.

Now scientists are connecting the dots with evidence of increasing abnormalities among humans, particularly large increases in numbers of genital deformities among newborn boys. For example, up to 7 percent of boys are now born with undescended testicles, although this often self-corrects over time. And up to 1 percent of boys in the United States are now born with hypospadias, in which the urethra exits the penis improperly, such as at the base rather than the tip.

Apprehension is growing among many scientists that the cause of all this may be a class of chemicals called endocrine disruptors. They are very widely used in agriculture, industry and consumer products. Some also enter the water supply when estrogens in human urine — compounded when a woman is on the pill — pass through sewage systems and then through water treatment plants.

These endocrine disruptors have complex effects on the human body, particularly during fetal development of males.

“A lot of these compounds act as weak estrogen, so that’s why developing males — whether smallmouth bass or humans — tend to be more sensitive,” said Robert Lawrence, a professor of environmental health sciences at the Johns Hopkins Bloomberg School of Public Health. “It’s scary, very scary.”

The scientific case is still far from proven, as chemical companies emphasize, and the uncertainties for humans are vast. But there is accumulating evidence that male sperm count is dropping and that genital abnormalities in newborn boys are increasing. Some studies show correlations between these abnormalities and mothers who have greater exposure to these chemicals during pregnancy, through everything from hair spray to the water they drink.

Endocrine disruptors also affect females. It is now well established that DES, a synthetic estrogen given to many pregnant women from the 1930s to the 1970s to prevent miscarriages, caused abnormalities in the children. They seemed fine at birth, but girls born to those women have been more likely to develop misshaped sexual organs and cancer.

There is also some evidence from both humans and monkeys that endometriosis, a gynecological disorder, is linked to exposure to endocrine disruptors. Researchers also suspect that the disruptors can cause early puberty in girls.

A rush of new research has also tied endocrine disruptors to obesity, insulin resistance and diabetes, in both animals and humans. For example, mice exposed in utero even to low doses of endocrine disruptors appear normal at first but develop excess abdominal body fat as adults.

Among some scientists, there is real apprehension at the new findings — nothing is more terrifying than reading The Journal of Pediatric Urology — but there hasn’t been much public notice or government action.

This month, the Endocrine Society, an organization of scientists specializing in this field, issued a landmark 50-page statement. It should be a wake-up call.

“We present the evidence that endocrine disruptors have effects on male and female reproduction, breast development and cancer, prostate cancer, neuroendocrinology, thyroid, metabolism and obesity, and cardiovascular endocrinology,” the society declared.

“The rise in the incidence in obesity,” it added, “matches the rise in the use and distribution of industrial chemicals that may be playing a role in generation of obesity.”

The Environmental Protection Agency is moving toward screening endocrine disrupting chemicals, but at a glacial pace. For now, these chemicals continue to be widely used in agricultural pesticides and industrial compounds. Everybody is exposed.

“We should be concerned,” said Dr. Ted Schettler of the Science and Environmental Health Network. “This can influence brain development, sperm counts or susceptibility to cancer, even where the animal at birth seems perfectly normal.”

The most notorious example of water pollution occurred in 1969, when the Cuyahoga River in Ohio caught fire and helped shock America into adopting the Clean Water Act. Since then, complacency has taken hold.

Those deformed frogs and intersex fish — not to mention the growing number of deformities in newborn boys — should jolt us once again.

Maine CDC Autism Conference: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? by Jon Poling, MD, PhD

Maine CDC Autism Conference 2009
Looking Forward Beyond Vaccines: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? Followed by Q&A with other conference speakers.
Jon Poling, MD, PhD
Neurologist, Clinical Assistant Professor
Medical College of Georgia
Father of child with autism

Maine CDC Autism Conference: Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science by Martha Herbert, MD, PhD

Maine CDC Autism Conference 2009
Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science, followed by Q&A
Martha Herbert, MD, PhD
Pediatric Neurologist
Massachusetts General Hospital
Harvard Medical School



Next Session:
Looking Forward Beyond Vaccines: How Do We Know What Autism IS NOT if We Do Not Know What Autism IS? by Jon Poling, MD, PhD

Maine CDC Autism Conference: Kim Block of WGME Presents News Piece on Autism

Maine CDC Autism Conference 2009
Kim Block, reporter for WGME, presents a news piece on autism treatment






Next Session:
Genes and Environment, Developmental and Chronic: An Inclusive Approach to Autism Science by Martha Herbert, MD, PhD

Maine CDC Autism Conference: Gastrointestinal and Nutritional Co-Morbidities in Autism by Tim Buie, MD

Maine CDC Autism Conference 2009
Gastrointestinal and Nutritional Co-Morbidities in Autism, followed by Q&A
Tim Buie, MD
Pediatric Gastroenterologist
LADDERS Program, MassGeneral Hospital for Children
Harvard Medical School



Questions from the Audience



Next Session:
Kim Block from WGME presents news piece on Autism treatment.

Maine CDC Autism Conference: Autism 101

Maine CDC Autism Conference 2009
Autism 101, First signs and symptoms, Maine’s new screening tool, how and when to refer for specialized diagnostics, how a diagnosis is made, AAP Autism Toolkit, diagnostic and therapeutic services in Maine.
Introduction of Speakers by Dora Mills, MD, MPH




Autism 101
Early Identification and Autism Prevalence
Nancy Cronin, Coordinator of the PDD Systems Change Initiative




Autism 101
Common understanding of what children with autism look like
Mary Ellen Gellerstedt, MD
Developmental-Behavioral Pediatrician
Eastern Maine Medical Center




Autism 101
Screening for Autism Spectrum Disorders
Victoria Dalzell, MD
Developmental-Behavioral Pediatrics
Barbara Bush Children's Hospital
Maine Medical Center



Autism 101
Developmental Screening in the Office
Donald Burgess, MD, FAAP



Autism 101
Diagnostic and Medical Evaluation, Intervention and Office Visits for Children on the Autism Spectrum
Carol Hubbard, MD
Developmental-Behavioral Pediatrician
Maine Medical Center



Autism 101
Questions from the Audience




Next Session:
Gastrointestinal and Nutritional Co-Morbidities in Autism by Tim Buie, MD

Maine CDC Autism Conference: Intro by Dora Mills

As I have previously mentioned, in May the Maine CDC held a one day conference on Autism. The videos of the conference will be available on the Maine CDC web site, however Maine state law requires that they be ADA compliant before going up, and the process of close captioning the videos is proving to be time consuming. So in my impatience, I am uploading my copies of the videos (with permission from Maine CDC who is encouraging their free circulation.)

Conference materials available here on the Maine CDC web site.

Those who would like a set of DVD's of the conference, for yourself, your organization or to pass along to doctors and public health officials, email me.

Maine CDC Autism Conference 2009
Introduction and Overview of Autism in Maine
Dora Anne Mills, MD, MPH
Director, Maine Center for Disease Control and Prevention, State Health Officer
with Becky Grant-Widen, Board Member of the National Autism Association



Next session:
Autism 101: First signs and symptoms, Maine’s new screening tool, how and when to refer for specialized diagnostics, how a diagnosis is made, AAP Autism Toolkit, diagnostic and therapeutic services in Maine.

Monsanto's Roundup Kills Human Cells

Our children have been eating poisoned foods. Keep in mind, this substance is one of the "inert" ingredients in Roundup, that actually turned out to be more deadly than the actual herbicide itself.

Scientific American:

Weed-Whacking Herbicide Proves Deadly to Human Cells
Used in gardens, farms, and parks around the world, the weed killer Roundup contains an ingredient that can suffocate human cells in a laboratory, researchers say

By Crystal Gammon and Environmental Health News


WEED KILLER: New research has found that an 'inert' ingredient in the herbicide Roundup can kill human embryonic, placental, and umbilical cord cells

Used in yards, farms and parks throughout the world, Roundup has long been a top-selling weed killer. But now researchers have found that one of Roundup’s inert ingredients can kill human cells, particularly embryonic, placental and umbilical cord cells.

The new findings intensify a debate about so-called “inerts” — the solvents, preservatives, surfactants and other substances that manufacturers add to pesticides. Nearly 4,000 inert ingredients are approved for use by the U.S. Environmental Protection Agency.

Glyphosate, Roundup’s active ingredient, is the most widely used herbicide in the United States. About 100 million pounds are applied to U.S. farms and lawns every year, according to the EPA.

Until now, most health studies have focused on the safety of glyphosate, rather than the mixture of ingredients found in Roundup. But in the new study, scientists found that Roundup’s inert ingredients amplified the toxic effect on human cells—even at concentrations much more diluted than those used on farms and lawns.

One specific inert ingredient, polyethoxylated tallowamine, or POEA, was more deadly to human embryonic, placental and umbilical cord cells than the herbicide itself – a finding the researchers call “astonishing.”

“This clearly confirms that the [inert ingredients] in Roundup formulations are not inert,” wrote the study authors from France’s University of Caen. “Moreover, the proprietary mixtures available on the market could cause cell damage and even death [at the] residual levels” found on Roundup-treated crops, such as soybeans, alfalfa and corn, or lawns and gardens.

The research team suspects that Roundup might cause pregnancy problems by interfering with hormone production, possibly leading to abnormal fetal development, low birth weights or miscarriages.

Monsanto, Roundup’s manufacturer, contends that the methods used in the study don’t reflect realistic conditions and that their product, which has been sold since the 1970s, is safe when used as directed. Hundreds of studies over the past 35 years have addressed the safety of glyphosate.

“Roundup has one of the most extensive human health safety and environmental data packages of any pesticide that's out there,” said Monsanto spokesman John Combest. “It's used in public parks, it's used to protect schools. There's been a great deal of study on Roundup, and we're very proud of its performance.”

Just to break in here for a second... Round up is protecting schools? From what, giant killer weeds that attack school children?

Apparently this guy has studied "Thank You For Smoking" in depth.

The EPA considers glyphosate to have low toxicity when used at the recommended doses.

“Risk estimates for glyphosate were well below the level of concern,” said EPA spokesman Dale Kemery. The EPA classifies glyphosate as a Group E chemical, which means there is strong evidence that it does not cause cancer in humans.

In addition, the EPA and the U.S. Department of Agriculture both recognize POEA as an inert ingredient. Derived from animal fat, POEA is allowed in products certified organic by the USDA. The EPA has concluded that it is not dangerous to public health or the environment.

Pardon me again... but does any one believe anything the EPA says anymore?

The French team, led by Gilles-Eric Seralini, a University of Caen molecular biologist, said its results highlight the need for health agencies to reconsider the safety of Roundup.

“The authorizations for using these Roundup herbicides must now clearly be revised since their toxic effects depend on, and are multiplied by, other compounds used in the mixtures,” Seralini’s team wrote.

Controversy about the safety of the weed killer recently erupted in Argentina, one of the world’s largest exporters of soy.